GlassScriptPhysician profile
Kristen K Buono
NPI 1245573039
$4,872.17
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.90 · 2020: $190 · 2021: $1,449 · 2022: $1,960 · 2023: $1,005 · 2024: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939 · Education: $185 · Gift: $57.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.41 |
| Education | $184.98 |
| Gift | $57.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,292.90 | 2020-2024 | Axonics |
| Pfizer INC. | $592.59 | 2020-2023 | |
| Astellas Pharma US INC | $448.55 | 2021-2024 | Myrbetriq, Veozah |
| Boston Scientific Corporation | $437.71 | 2019-2023 | Solyx Sis System, Upsylon |
| Allergan, INC. | $345.04 | 2020-2022 | |
| Coloplast Corp | $225.49 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $156.02 | 2023-2024 | Gemtesa |
| Urovant Sciences INC | $125.04 | 2022 | |
| Medtronic USA, INC. | $64.38 | 2019 | |
| Caldera Medical, INC | $57.69 | 2023 | Desara |
| Abbvie INC. | $48.01 | 2023-2024 | Botox |
| Therapeuticsmd, INC. | $46.91 | 2020-2022 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Hologic Sales and Service, LLC | $15.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Buono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.